In recent years, an increasing number of studies have suggested that certain herbal formulations and extracts derived from Traditional Chinese Medicine (TCM) may influence the pathological processes of Alzheimer’s disease (AD) by modulating the PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.